Population Pharmacokinetic Modeling and Determination of Individual Exposure to Avalglucosidase Alfa in Adolescent and Adult Patients With Late-Onset Pompe Disease: Analysis of Poo...

por Tuffal, Gilles, Tiraboschi, Gilles, Hurbin, Fabrice, Boittet, Pascale, Palmer, Rachel, Martinez, Jean-Marie, Fabre, David
Publicado 2023

Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies

por Djebli, Nassim, Martinez, Jean-Marie, Lohan, Laura, Khier, Sonia, Brunet, Aurélie, Hurbin, Fabrice, Fabre, David
Publicado 2017

Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lip...

por Nicolas, Xavier, Djebli, Nassim, Rauch, Clémence, Brunet, Aurélie, Hurbin, Fabrice, Martinez, Jean-Marie, Fabre, David
Publicado 2018

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Dispositio...

por Martinez, Jean-Marie, Brunet, Aurélie, Hurbin, Fabrice, DiCioccio, A. Thomas, Rauch, Clémence, Fabre, David
Publicado 2018

Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease

por Tiraboschi, Gilles, Marchionni, David, Tuffal, Gilles, Fabre, David, Martinez, Jean-Marie, Haack, Kristina An, Miossec, Patrick, Kittner, Barbara, Daba, Nadia, Hurbin, Fabrice
Publicado 2023

Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies

por Naccarelli, Gerald V., Bhatt, Deepak L., Camm, A. John, Le Heuzey, Jean-Yves, Lombardi, Federico, Tamargo, Juan, Martinez, Jean-Marie, Naditch-Brûlé, Lisa
Publicado 2020